116 related articles for article (PubMed ID: 6762195)
1. Immunotherapy maintenance in acute non-lymphocytic leukaemia.
Paton CM; Bishop JF; Mathews JD; Whiteside MG
Aust N Z J Med; 1982 Dec; 12(6):583-9. PubMed ID: 6762195
[TBL] [Abstract][Full Text] [Related]
2. A randomized comparison of maintenance treatment with androgens, immunotherapy, and chemotherapy in adult acute myelogenous leukemia. A Leukemia-Lymphoma Group Trial of the EORTC.
Hayat M; Jehn U; Willemze R; Haanen C; Zittoun R; Monconduit M; Lowenberg B; Stryckmans P; Peetermans M; De Cataldo F
Cancer; 1986 Aug; 58(3):617-23. PubMed ID: 3524789
[TBL] [Abstract][Full Text] [Related]
3. Treatment of acute myelogenous leukemia: influence of three induction regimens and maintenance with chemotherapy or BCG immunotherapy.
Omura GA; Vogler WR; Lefante J; Silberman H; Knospe W; Gordon D; Jarrell R
Cancer; 1982 Apr; 49(8):1530-6. PubMed ID: 7039813
[TBL] [Abstract][Full Text] [Related]
4. [Non-lymphoblastic acute leukaemia: maintenance therapy by trial of a combination of chemo- and immunotherapy (author's transl)].
Sébahoun G; Gastaut JA; Imbert-Xeridat C; Favre R; Carcassonne Y
Nouv Presse Med; 1979 Feb; 8(9):663-5. PubMed ID: 377219
[TBL] [Abstract][Full Text] [Related]
5. Remission maintenance for acute nonlymphocytic leukemia: cytosine arabinoside plus 6-thioguanine versus a sequence of drug regimens.
Presant CA; Berger NA; Klahr C; Phillips GL
Cancer; 1980 Jul; 46(1):22-8. PubMed ID: 6930320
[TBL] [Abstract][Full Text] [Related]
6. Immunotherapy alone vs no maintenance treatment in acute myelogenous leukaemia.
Zuhrie SR; Harris R; Freeman CB; MacIver JE; Geary CG; Delamore IW; Tooth JA
Br J Cancer; 1980 Mar; 41(3):372-7. PubMed ID: 6992827
[TBL] [Abstract][Full Text] [Related]
7. The immunotherapy of acute myelogenous leukaemia using intravenous BCG.
Whittaker JA; Slater AJ
Br J Haematol; 1977 Feb; 35(2):263-73. PubMed ID: 322696
[TBL] [Abstract][Full Text] [Related]
8. Active immunotherapy in acute myelogenous leukaemia and the induction of second and subsequent remissions.
Harris R; Zuhrie SR; Freeman CB; Taylor GM; MacIver JE; Geary CG; Delamore IW; Hull PJ; Tooth JA
Br J Cancer; 1978 Feb; 37(2):282-8. PubMed ID: 272913
[TBL] [Abstract][Full Text] [Related]
9. Management of adult acute myelogenous leukaemia.
Crowther D; Powles RL; Bateman CJ; Beard ME; Gauci CL; Wrigley PF; Malpas JS; Fairley GH; Scott RB
Br Med J; 1973 Jan; 1(5846):131-7. PubMed ID: 4513355
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant specific immunotherapy in maintenance treatment of adult acute non-lymphocytic leukemia.
Rühl H; Fülle HH; Koeppen KM; Schwerdtfeger R
Klin Wochenschr; 1981 Nov; 59(21):1189-93. PubMed ID: 6947118
[TBL] [Abstract][Full Text] [Related]
11. Therapy of acute myelogenous leukemia in patients over the age of 50: a randomized Southeastern Cancer Study Group trial.
Stein RS; Vogler WR; Winton EF; Cohen HJ; Raney MR; Bartolucci A
Leuk Res; 1990; 14(10):895-903. PubMed ID: 2259226
[TBL] [Abstract][Full Text] [Related]
12. Prolonged remission maintenance in acute myeloid leukaemia.
Spiers AS; Goldman JM; Catovsky D; Costello C; Galton DA; Pitcher CS
Br Med J; 1977 Aug; 2(6086):544-7. PubMed ID: 268229
[TBL] [Abstract][Full Text] [Related]
13. Randomized multicenter trial of cytosine arabinoside with mitoxantrone or daunorubicin in previously untreated adult patients with acute nonlymphocytic leukemia (ANLL). Lederle Cooperative Group.
Arlin Z; Case DC; Moore J; Wiernik P; Feldman E; Saletan S; Desai P; Sia L; Cartwright K
Leukemia; 1990 Mar; 4(3):177-83. PubMed ID: 2179638
[TBL] [Abstract][Full Text] [Related]
14. Treatment of refractory adult acute lymphocytic leukaemia and acute undifferentiated leukaemia with an anthracycline antibiotic and cytosine arabinoside.
Early AP; Preisler HD; Gottlieb AJ; Lanchant NA
Br J Haematol; 1981 Jul; 48(3):369-75. PubMed ID: 7259987
[TBL] [Abstract][Full Text] [Related]
15. Dose intensification in acute myeloid leukaemia: greater effectiveness at lower cost. Principal report of the Medical Research Council's AML9 study. MRC Leukaemia in Adults Working Party.
Rees JK; Gray RG; Wheatley K
Br J Haematol; 1996 Jul; 94(1):89-98. PubMed ID: 8757514
[TBL] [Abstract][Full Text] [Related]
16. Adult acute leukaemia.
Atkinson K; Wells DG; Clink HM; Kay HE; Powles R; McElwain TJ
Br J Cancer; 1974 Sep; 30(3):272-8. PubMed ID: 4141625
[TBL] [Abstract][Full Text] [Related]
17. Randomized study of individualized induction therapy with or without vincristine, and of maintenance-intensification therapy between 4 or 12 courses in adult acute myeloid leukemia. AML-87 Study of the Japan Adult Leukemia Study Group.
Ohno R; Kobayashi T; Tanimoto M; Hiraoka A; Imai K; Asou N; Tomonaga M; Tsubaki K; Takahashi I; Kodera Y
Cancer; 1993 Jun; 71(12):3888-95. PubMed ID: 8508355
[TBL] [Abstract][Full Text] [Related]
18. Chemotherapy for adult acute nonlymphocytic leukemia with daunorubicin and cytosine arabinoside.
Cassileth PA; Katz ME
Cancer Treat Rep; 1977 Nov; 61(8):1441-5. PubMed ID: 922749
[TBL] [Abstract][Full Text] [Related]
19. [Breakthrough in hematology?].
Reizenstein P
Lakartidningen; 1974 Aug; 71(32):2925-8. PubMed ID: 4605540
[No Abstract] [Full Text] [Related]
20. The effect of immunotherapy on survival of patients with acute myelogenous leukaemia after relapse.
Powles R; Toy JL
Haematologia (Budap); 1976; 10(1):5-9. PubMed ID: 1070466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
